News
What if a cancer patient could receive life-saving cellular therapy within days of diagnosis rather...
April 14, 2021
2021 Cell & Gene Meeting on the Med organized by the Alliance for Regenerative Medicine, was held...
April 06, 2021
Greg Crescenzi Joins Kytopen as Chief Commercial Officer to Drive Discovery, Development and...
March 29, 2021
BioCentriq™, the New Jersey Innovation Institute’s cell and gene therapy development and...
March 23, 2021
Kytopen co-founder Professor Cullen Buie studied mechanical engineering, first at Ohio State, then...
February 02, 2021
MIT spin-out company Kytopen has engaged Cambridge Consultants to co-develop the first Flowfect™...
January 20, 2021
Kytopen, an MIT spin-out company, and Cambridge Consultants, part of Capgemini, announce the...
October 28, 2020
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Kytopen, a technology startup accelerating the discovery and...
May 28, 2019
Merck, a leading science and technology company, today announced the winners of its Advance Biotech...
February 04, 2019
IF THE GENETIC REVOLUTION HAS YET TO DELIVER FULLY ON ITS PROMISE, Cullen Buie, associate professor...
October 13, 2018